Short on Time? Half a Million Reasons to Hope Explained
- What does “Half a Million Reasons to Hope” mean? As of April 2026, 500,000+ people have been prescribed Indivior’s long-acting injectable buprenorphine treatment for opioid use disorder (OUD). This number symbolizes the half-million patients and families who are taking steps towards meaningful recovery.
- What does 500,000+ prescriptions mean to Indivior? This milestone reflects an important step in Indivior’s continued progress toward expanding access to evidence-based treatment for OUD. It is a reminder to reflect on the inspiring work our team has accomplished and the work still ahead of us.
Indivior’s Commitment to Powering Recovery
Building on Indivior’s 25-year legacy, we are reaffirming our commitment to improving the lives of individuals with opioid use disorder (OUD). As of April 2026, 500,000+ people have been prescribed our long-acting injectable buprenorphine treatment for OUD.
This number symbolizes the half-million patients and families who are taking steps towards meaningful recovery. Behind every prescription is a person, their community, and a step forward on the path to recovery. It’s a parent who can be present again. A friend who watches someone they love find their way back to themselves. A child who can keep their hero.
This reflects an important step in Indivior’s continued progress toward expanding access to evidence-based treatment for OUD. And it is a time to reflect on the inspiring work our team has accomplished, and the work still ahead of us.
As part of our recent All-Employee Meeting and in honor of the 500,000 prescriptions milestone, Indivior team members packed 500 support bags for REAL LIFE, an organization creating pathways for individuals transitioning out of jail, living with substance use disorder, or experiencing homelessness.
These conversations reinforced the importance of making information about the full spectrum of medication for opioid use disorder (MOUD) options accessible to frontline providers in community settings. MOUD — sometimes called medication-assisted treatment (MAT) — uses FDA-approved medications combined with counseling and behavioral therapies to treat OUD and support long-term recovery.
Indivior employees also had the chance to personally write and place messages of inspiration, gratitude, or reflections on what 500,000 prescriptions mean to them on an interactive banner.
The team’s involvement in these activations shows how dedicated Indivior employees are to progressing research and treatment innovation in OUD, anchored in the belief that meaningful, long-term recovery is possible. Now, we have half a million reasons to continue our work.
Share